Concepedia

Suzannah J. Harnor

SJ

Statistics

Publications

9

Citations

302

H-Index

9

Active since

2013

Affiliations

Newcastle University(Current)

University of Oxford

Cancer Research UK

Suzannah J. Harnor is an author at Newcastle University specializing in pharmacology, medicinal chemistry, and pharmacy.

ORCID

Publications per year

2013–2021

9

Publications

9

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines

Christopher R. Coxon, Elizabeth Anscombe, Suzannah J. Harnor et al. · Journal of Medicinal Chemistry · 2016 · 119 citations · Full text

, , +17

Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein–Protein Interaction

Gianni Chessari, Ian R. Hardcastle, Jong Sook Ahn et al. · Journal of Medicinal Chemistry · 2021 · 53 citations

, , +12

Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification

S. Hill, Michael Dunn, Céline Cano et al. · Clinical Chemistry · 2017 · 29 citations

, , +17

Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4

Stephanie M. Myers, Duncan C. Miller, Lauren Molyneux et al. · European Journal of Medicinal Chemistry · 2019 · 22 citations · Full text

, , +8

2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase

Christopher J. Matheson, Christopher R. Coxon, Richard Bayliss et al. · RSC Medicinal Chemistry · 2020 · 18 citations · Full text

, , +14

1–5 of 9